COVID Archives | Frier Levitt

Employment Law Alert: Families First Coronavirus Response Act (FFCRA) set to expire on December 31, 2020; no renewal in sight

Sean E. Sanders, Esq. and Michelle L. Greenberg, Esq. December 21, 2020

Despite the continuing increase in COVID-19 cases and the limit on gatherings, the Families First Coronavirus Response Act (FFCRA) will expire on December 31, 2020. Enacted in March 2020, the FFCRA provided extra expanded leave entitlements to... Read More

NJ Executive Order Permitting the Resumption of Elective Surgeries and Invasive Procedures Effective May, 26, 2020- Significant Requirements Must be Followed

Marc H. Mayer, Esq., Daniel B. Frier, Esq. and Jason N. Silberberg, Esq. May 21, 2020

On May 15, 2020, Governor Murphy issued Executive Order No. 145 (“EO-145”), which lifts, subject to certain restrictions, the suspension of elective surgeries and invasive procedures effective May 26, 2020, ending a 60-day suspension imposed by... Read More

COVID-19 Resources | Healthcare Law | Healthcare Practice Compliance

First of Many CARES Act Prosecutions Initiated

Daniel G. Giaquinto, Esq. and Kendra E. Pannitti, Esq. May 15, 2020

As a first in the nation, criminal complaints were filed recently in Federal Court in Rhode Island for fraud related to the seeking of more than a half million dollars in loans pursuant to the Coronavirus, Aid, Relief, and Economic Security... Read More

FDA Allows Pharmacies to Compound Drugs to Fill Hospitals’ Needs

Martha M. Rumore Pharm.D., Esq. and John E. Morrone, Esq. April 23, 2020

Over the last few days, FDA has issued several guidance documents relating to compounding of certain aqueous injectable drugs by outsourcing facilities, State-licensed pharmacies and Federal facilities for duration of the COVID-19 public health... Read More

The Risks of Distributing COVID-19 Therapies: What Wholesale Distributors Need to Know About Track and Trace

Paul H. Juzdan, Esq. April 20, 2020

Wholesale drug distributors need to maintain adequate track and trace documents, especially when acquiring and distributing COVID-19 therapies. The COVID-19 epidemic has sparked a demand for various drug products including, hydroxychloroquine. To... Read More

Frier Levitt Assisted Procurement of Much Needed COVID-19 Testing Kit into U.S.

Dae Y. Lee, Esq., Pharm.D CPBS and John E. Morrone, Esq. April 20, 2020

Frier Levitt is pleased to announce that its COVID-19 Task Force assisted a national distributor to obtain an authorized distributorship of COVID-19 testing kits from a renowned South Korean manufacturer. This is a crucial development amid the... Read More

What Are the PBMs Doing Amid COVID-19 Crisis: Waivers from Strict Requirements May Exist for Independent Pharmacies

Payal Amin, Pharm.D., RPh, Esq. and Jesse C. Dresser, Esq. March 29, 2020

During this unprecedented time of the COVID-19 crisis, companies across every industry are taking immediate actions to help stem the spread of the virus and to ensure access to essential services. These immediate efforts are only that much more... Read More

Let’s Talk: COVID-19 and Elective Surgeries

Jonathan E. Levitt, Esq. and John E. Morrone, Esq. March 26, 2020

https://www.youtube.com/watch?v=AB_P7D2JF14&feature=youtu.be Frier Levitt Co-Founding Partner Jonathan Levitt, Esq. and Managing Partner John Morrone, Esq. discuss the COVID-19 pandemic as it pertains to providers. Recently, Medicare has... Read More

Let’s Talk: COVID-19 and Healthcare Providers Ability to Provide Care

Jonathan E. Levitt, Esq. and Jesse C. Dresser, Esq. March 18, 2020

https://youtu.be/hSnWv8Wz3js In response to the recent COVID-19 outbreak and its impact on providers Jonathan Levitt and Jesse Dresser have created a series of videos talking about some of the issues healthcare and pharmacy clients are facing and... Read More

COVID-19 Resources

Tag: COVID